Yd Diagnostics

Yd Diagnostics specializes in rapid colorimetric in-vitro diagnostic (IVD) test kits designed for clinical use. Their primary products include urine analyte strips that detect specific substances like glucose, ketones, protein, pH, specific gravity, leucocytes, nitrites, blood, bilirubin, and urobilinogen. Additionally, they produce a rapid test for detecting faecal occult blood in stool samples, which is useful for early screening of gastrointestinal conditions.

Yd Diagnostics is based in the United States. Its devices are regulated under the FDA’s classification system, with most falling into Class I (generally low-risk) or Class II (moderate-risk) categories. The company’s products are authorised either through the 510(k) pathway—a premarket submission process for devices similar to existing approved products—or listed under the FDA’s Unique Device Identifier (UDI) system, which ensures traceability and compliance for lower-risk devices.

Yd Diagnostics’ devices are documented in the FDA’s 510(k) database for those authorised via the 510(k) pathway, as well as the FDA’s Unique Device Identifier (UDI) system, which maintains records of listed medical devices. These registries ensure transparency and compliance with U.S. regulatory requirements for in-vitro diagnostics, helping healthcare providers verify the authorised status of specific products.

The FDA classifies Yd Diagnostics’ devices into Class I (for generally low-risk products like some urine analyte strips) or Class II (for moderate-risk devices, such as certain faecal occult blood tests). Classification depends on factors like the device’s intended use, potential risks, and the level of regulatory oversight needed. Class II devices typically require additional controls to ensure safety and effectiveness, while Class I devices may only need general controls like good manufacturing practices.

Yd Diagnostics’ devices, including urine analyte strips and faecal occult blood tests, are explicitly designed for clinical use in healthcare settings. These tests are intended to be performed by trained medical professionals or in environments where proper interpretation and follow-up care can be provided, ensuring accurate diagnosis and appropriate patient management.